OSTEOGROW među najperspektivnijim EU programima

Objavljeno 13.02.2017.

Europska Komisija je proglasila program OSTEOGROW jednim od najperspektivnijih europskih programa u polju Biologije i Medicine kojim se uvodi nova regenerativna terapiju za popravak kostiju.

U posljednjem broju European Commission Research Magazine predstavlja program OSTEOGROW na naslovnoj stranici, te isti ukratko opisuje na stranici 13 (pdf ispod teksta). Magazin je prikazan članovima EU parlamenta te mnogim europskim znanstvenim i profesionalnim institucijama. Tim programa OSTEOGROW nije sudjelovao u pripremi teksta niti je bio obavješten o odluci Europske Komisije.

Ovo izuzetno važno priznanje dodatna je motivacija cjelokupnom timu programa OSTEOGROW da nastavi s napornim radom kako bi ovu novu regenerativnu terapiju doveli do pacijenata čiji medicinski problemi nemaju odgovarajuće terapijsko rješenje.

research-eu_magazine_no58 short

Povratak na stranicu vijesti

OSTEOGROW among the most promising EU programs

Objavljeno 13.02.2017.

European Commission recognized OSTEOGROW project as one of the most promising European programs in the Biology and Medicine field to pioneer new regenerative therapy for bone repair.

The last issue of the European Commission Research Magazine presents OSTEOGROW program on the cover page, highlighted on page 3 and summarized on page 13 (see attachment). The Magazine is offered to members of the EU parliament and throughout European scientific and professional institutions. OSTEOGROW team did not participate in the preparation of the text, neither was informed of the EU Commission decision.

This important acknowledgement will motivate OSTEOGROW team to continue working hard in bringing this novel regeneration therapy to patients with unmet medical needs.

research-eu_magazine_no58 short